exenatide vs tirzepatide PDB-101: Molecule of the Month: GLP-1 Receptor Agonists GLP-1 Medications: What You Need

however, there are limited studies on its effectiveness in Japanese patients with type 2 diabetes diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD)

Interview Courtesy | Ankit Kankar #GLP1 #Diabetes #Obesity #Cardiology #Metabolism #Therapeutics #Innovation #Healthcare #Medicine #Research #Pharmacology #Biotechnology #Clinicaltrials #Prevention #Wellness

Nausea affects up to 25% of semaglutide users in early treatment phases

Originally developed to treat type 2 diabetes, semaglutide works by mimicking a hormone called GLP-1 that targets areas of the brain involved in regulating appetite and food intake